Nature Exposure Through Virtual Reality (NET-VR) in Older Adults (NET-VR)

February 24, 2026 updated by: Universitat Internacional de Catalunya
Daily exposure to nature is associated with improved mood and reduced anxiety symptoms in the overall population. Even brief contact with natural environments can lower stress and restore productivity.However, access to natural environments is often limited, particularly for urban and institutionalized older adults, due to physical, financial, and logistical barriers.These challenges highlight the need for new technologies that can facilitate more regular contact with nature. Virtual Reality (VR)-a digital technology that creates realistic scenes and objects to simulate the experience of being in a natural environment-offers a promising solution, particularly for older adults with physical or financial limitations.The aim of this study is to explore how both older adults might benefit from a mental health program that uses virtual reality to simulate exposure to nature.

Study Overview

Detailed Description

This study aims to evaluate the feasibility and effectiveness of a virtual reality (VR) system featuring nature-based environments to improve emotional well-being, reduce psychological distress, and enhance cognitive functioning in older adults.

To achieve this, participants will be assigned to one of two groups: an experimental group that will receive the nature-based VR intervention, and a control group placed on a waiting list. The intervention is expected to have a positive impact on self-reported measures such as mindful awareness, anxiety, depression and cognitive functions (particularly attention and executive functioning) Additionally, usability-related aspects of the technology-such as presence, ease of use, and cybersickness-will also be assessed.

A total of 30 participants will be recruited (aged 60 to 90). Participation is voluntary and will take place at the International University of Catalonia (UIC Barcelona), through face-to-face group sessions.

The intervention will span 5 weeks, with two 30-minute session per week. Participants will use a VR headset to explore immersive natural environments (e.g., tropical islands, forests, snowy landscapes) via the Nature Treks VR software. Each session will follow a structured protocol with three stages: a training stage, a personalization stage, and a final immersive relaxation stage.

Before enrollment, participants will undergo an eligibility screening to ensure they meet the inclusion and exclusion criteria, particularly regarding mental and cognitive health. Group allocation will be randomized, and outcome assessments will be conducted by blinded evaluators to reduce bias.

This study aims to contribute new evidence on the psychological and cognitive benefits of nature-based VR interventions and their usability across different age groups, supporting the development of accessible and innovative tools for mental health and well-being.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain
        • Universitat Internacional de Catalunya

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  1. being between 60 and 90 years old;
  2. normal or corrected-to-normal vision and hearing.

Exclusion criteria (all self-reported:

  1. high risk of anxiety and depressive disorders, as assessed by the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder (GAD-7)
  2. Other serious mental disorders with psychotic or manic symptoms (e.g., psychotic disorders, bipolar disorders, etc.), sensory complications that would prevent exposure (e.g., visual or auditory deficits), epilepsy, and other medical conditions (such as, balance/vestibular problem) that would disrupt the VR experience.
  3. High risk of cognitive impairment as assessed by the Montreal Cognitive Assessment (MoCA test).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Nature VR-based Sessions: The intervention lasts 5 weeks, with sessions twice weekly, 30 minutes each (10 sessions total). Participants use a single IVR headset in face-to-face groups of up to five, supervised by a PhD-level mental health expert. Completion requires attending ≥80% of sessions. The Nature-Trek VR software (Greener Games, USA) simulates diverse natural environments such as tropical islands, forests, lakes, and snow-covered landscapes. Each session features a unique environment. Sessions have three stages: (1) Training (first session only, no direct VR use), (2) Tailoring the VR nature environment, and (3) Immersion, where participants relax and experience the VR setting. Participants remain seated in comfortable chairs with wheels throughout.
This intervention uses the commercially available Nature-Trek VR software to immerse participants in diverse natural environments through a virtual reality headset. It is delivered face-to-face in small groups, supervised by a mental health expert, over 5 weeks with twice-weekly 30-minute sessions. The intervention includes a training session, customization of the VR nature environment, and a relaxation immersion stage. It specifically targets reduction of psychological distress and enhancement of cognitive functioning in both young and older adults.
Other Names:
  • VR Nature Exposure Intervention
  • Nature-Trek VR
  • Nature-Based Immersive VR
Other: Control group - waiting list
Participants assigned to the waiting list arm will not receive the VR intervention during the initial 5-week study period and will continue their usual daily routines without any study-related intervention. After the study period, they will be offered the opportunity to experience a single VR session
Participants assigned to the waiting list arm will not receive the VR intervention during the initial 5-week study period and will continue their usual daily routines without any study-related intervention. After the study period, they will be offered the opportunity to experience a single VR session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood - Positive and Negative Affect Schedule
Time Frame: Baseline and post-intervention (after 5 weeks)
The Positive and Negative Affect Schedule (PANAS) assess two broad domains of affect, termed Positive Affect (PA) and Negative Affect (NA). Both PA and NA represent largely independent constructs ranging from low to high levels of emotional experience . Low PA scores reflect 'sadness and lethargy' whereas high PA scores reflect 'high energy, full concentration, and pleasurable engagement'. Low NA scores describe 'a state of calmness and serenity' whereas high NA scores suggest 'subjective distress and unpleasurable engagement'. The PANAS contains 20 items that yield two subscales (PA, NA) of 10 adjectives each. Participants responded with regards to how they felt 'during the past week' on a 5-point scale from very slightly to very much. Minimum score is 20 and maximum score is 100.
Baseline and post-intervention (after 5 weeks)
Beck Depression Inventory-II
Time Frame: During and after each session; post-intervention (after 5 weeks)
It assesses the severity of depressive symptoms, specifically evaluating the intensity of depression in psychiatric and general populations aged 13 years and older. It consists of 21 items with four response options ranging from 0 (absence of the symptom) to 3 (greater severity of the symptom). It evaluates symptom severity over the past two weeks, including the day the inventory is completed. The total score ranges from 0 (no depression) to 63 (severe depression).
During and after each session; post-intervention (after 5 weeks)
State-Trait Anxiety Inventory (STAI)
Time Frame: Baseline and post-intervention (after 5 weeks)
The State-Trait Anxiety Inventory (STAI) is a widely used self-report instrument designed to assess anxiety as both a transient emotional state (State Anxiety) and a relatively stable individual difference in anxiety proneness (Trait Anxiety). State Anxiety reflects temporary feelings of tension, nervousness, and apprehension that fluctuate over time and in response to situational stressors, whereas Trait Anxiety reflects a general tendency to perceive situations as threatening and to respond with elevated anxiety. The STAI consists of 40 items divided into two 20-item subscales (State and Trait). Participants rate the intensity or frequency of anxiety-related feelings on a 4-point Likert scale. Higher scores indicate greater levels of anxiety, with total scores ranging from 20 to 80 for each subscale.
Baseline and post-intervention (after 5 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mindful Attention Awareness Scale and Nature Exposure Scale-II
Time Frame: Baseline and post-intervention (after 5 weeks)
The Mindful Attention Awareness Scale (MAAS) is a self-report questionnaire designed to assess dispositional mindfulness, defined as an individual's capacity to maintain attention and awareness of present-moment experiences in everyday life. The scale focuses on the presence or absence of mindful attention, particularly lapses in awareness and automatic pilot behaviors. The MAAS consists of 15 items rated on a 6-point Likert scale (1 = Almost Always; 6 = Almost Never). Total scores range from 15 (minimum) to 90 (maximum), with higher scores indicating greater levels of mindful attention and awareness.
Baseline and post-intervention (after 5 weeks)
Contact with Nature Scale (ECN)
Time Frame: Baseline and post-intervention (after 5 weeks)
The Contact with Nature Scale (ECN) is a self-report instrument adapted into Spanish from the Nature Exposure Scale-II to measure individuals' direct contact with the natural environment. The scale consists of 6 items rated on a 5-point Likert scale (1 = Little/Not at all; 5 = Much/A lot), with total scores ranging from 6 (minimum) to 30 (maximum). Higher scores indicate greater contact with nature, covering everyday interactions, exposure outside routine environments, and contact during physical activity.
Baseline and post-intervention (after 5 weeks)
Stroop Color and Word Test (SCWT)
Time Frame: Baseline and post-intervention (after 5 weeks)
The Stroop Color and Word Test (SCWT) is a standardized neuropsychological measure of selective attention, cognitive flexibility, processing speed, and inhibitory control. The test consists of three conditions (word reading, color naming, and color-word interference), each administered with a 45-second time limit per condition, resulting in up to 3 scoring intervals of 45 seconds. Participants are asked to read words or name ink colors as quickly and accurately as possible within each time frame. Performance is measured by the number of correctly completed items per condition and the number of errors. The minimum possible score is 0 correct items per condition, and the typical maximum is determined by the number of items completed within the 45-second limit, with higher correct item counts indicating better cognitive performance (faster processing and stronger inhibitory control). Higher error counts indicate worse performance.
Baseline and post-intervention (after 5 weeks)
Trail Making Test (TMT A-B)
Time Frame: Baseline and post-intervention (after 5 weeks)
The Trail Making Test (TMT) is a widely used neuropsychological measure of visual attention, processing speed, cognitive flexibility, and executive function. It consists of two parts: TMT Part A, which requires participants to connect 25 numbered circles in sequential order as quickly as possible, assessing visual scanning, attention, and psychomotor speed; and TMT Part B, which requires connecting 25 circles alternating between numbers and letters (1-A-2-B…), assessing set-shifting, cognitive flexibility, and executive control. Performance is measured by completion time in seconds and errors for each part. The minimum possible time is 0 seconds, and there is no strict maximum; longer completion times and more errors indicate worse performance. Lower times and fewer errors indicate better cognitive function.
Baseline and post-intervention (after 5 weeks)
Digit Span
Time Frame: Baseline and post-intervention (after 5 weeks)
The Digit Span Subtest is a cognitive assessment tool that is part of the Weschler Adult Intelligence Test (WAIS), assesses auditory attention, immediate memory, working memory, and executive function. It consists of two conditions: Digit Span Forward and Digit Span Backward. In the Forward condition, participants repeat sequences of numbers presented orally in the same order; in the Backward condition, participants repeat the numbers in reverse order. Higher total correct scores indicate better attention, immediate memory (Forward), and working memory/executive control (Backward).
Baseline and post-intervention (after 5 weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Simulator Sickness Questionnaire (SSQ)
Time Frame: Post-intervention (after 5 weeks)
The Simulator Sickness Questionnaire (SSQ) is a self-report instrument designed to assess symptoms of motion sickness or discomfort experienced during or after virtual reality exposure. The SSQ consists of 16 items grouped into three subscales: Nausea, Oculomotor, and Disorientation. Participants rate the severity of each symptom on a 4-point Likert scale: 0 (None), 1 (Slight), 2 (Moderate), 3 (Severe). Total and subscale scores are calculated according to standardized formulas, with higher scores indicating greater severity of simulator-induced discomfort.
Post-intervention (after 5 weeks)
System Usability Scale (SUS)
Time Frame: Post-intervention (after 5 weeks)
The System Usability Scale (SUS) is a widely used 10-item self-report questionnaire designed to assess perceived usability of a system, product, or technology. Items are rated on a 5-point Likert scale from 1 (Strongly Disagree) to 5 (Strongly Agree), with scores converted to a 0-100 scale. Higher scores indicate better perceived usability.
Post-intervention (after 5 weeks)
Visual Analogue Scales (VAS) for Immersion, Enjoyment, and Relaxation
Time Frame: After each VR session (10 sessions per participant over 5 weeks)
Visual Analogue Scales (VAS) are self-report measures used to assess participants' subjective experiences after each VR session. Participants provide oral ratings after completing all immersive VR (IVR) tasks in the session. Each scale ranges from 0 (none) to 100 (absolutely). VAS scores assess immersion, enjoyment, and relaxation, with higher scores indicating greater perceived levels of each experience. These measures allow real-time evaluation of participants' engagement and affective response to the VR intervention.
After each VR session (10 sessions per participant over 5 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2024

Primary Completion (Actual)

December 30, 2025

Study Completion (Actual)

December 30, 2025

Study Registration Dates

First Submitted

July 23, 2025

First Submitted That Met QC Criteria

February 24, 2026

First Posted (Actual)

March 2, 2026

Study Record Updates

Last Update Posted (Actual)

March 2, 2026

Last Update Submitted That Met QC Criteria

February 24, 2026

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older Adults

Clinical Trials on Nature-Based Virtual Reality Intervention

Subscribe